Menu

 

Letter

Overtreatment

Response to Whitehead

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7088 (Published 24 October 2012)
Cite this as: BMJ 2012;345:e7088

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. David Colquhoun, research professor
  1. 1UCL, London WC1E 6BT, UK
  1. d.colquhoun{at}ucl.ac.uk

I guess one would expect the chief executive of the Association of the British Pharmaceutical Industry to respond by denying everything.1 2 But it is very condescending to …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Subscribe

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

Latest comments and most commented

THIS WEEK'S POLL

Read related article

See previous polls